scispace - formally typeset
A

Allmut Hörmann

Researcher at Free University of Berlin

Publications -  28
Citations -  2286

Allmut Hörmann is an academic researcher from Free University of Berlin. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 18, co-authored 28 publications receiving 2196 citations.

Papers
More filters
Journal ArticleDOI

Exposure to traffic and the onset of myocardial infarction.

TL;DR: Transient exposure to traffic may increase the risk of myocardial infarction in susceptible persons.
Journal ArticleDOI

Weekly variation of acute myocardial infarction. Increased Monday risk in the working population.

TL;DR: The onset of acute myocardial infarction demonstrates a peak on Monday primarily in the working population, and if this finding is confirmed in other communities, it may aid in identifying acute triggering events of myocardia infarctions and perhaps in improving prevention of the disease.
Journal ArticleDOI

Ambient Air Pollution Is Associated With Increased Risk of Hospital Cardiac Readmissions of Myocardial Infarction Survivors in Five European Cities

TL;DR: Cardiac readmissions increased in association with same-day concentrations of PM10, and ambient air pollution is associated with increased risk of hospital cardiac readmissions of myocardial infarction survivors in 5 European cities.
Journal ArticleDOI

The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment?

TL;DR: Diabetic patients after myocardial infarction are at particularly high risk of dying, but benefit clearly from treatment with thrombolytics, beta blockers and antiplatelets, according to this population-based evaluates the impact of cardiovascular drug therapy.
Journal ArticleDOI

The population-based acute myocardial infarction (AMI) registry of the MONICA/KORA study region of augsburg

TL;DR: Positive developments are shown, but the necessity for increased primary prevention is underscored as result of an intensified invasive reperfusion therapy and evidence-based drug medication.